-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS: UK NICE RECOMMENDS NHS FUNDING FOR REDEMPLO (PLOZASIRAN) FOR GENETICALLY CONFIRMED FCS IN ADULTS

Reuters·10/27/2026 15:36:28

Please log in to view news